Kirk Allan 4
4 · Eledon Pharmaceuticals, Inc. · Filed Jan 13, 2025
Insider Transaction Report
Form 4
Kirk Allan
Director
Transactions
- Award
Stock Option (right to buy)
2025-01-10+30,870→ 30,870 totalExercise: $4.04Exp: 2035-01-10→ Common Stock (30,870 underlying) - Award
Restricted Stock Units
2025-01-10+3,430→ 3,430 total→ Common Stock (3,430 underlying)
Footnotes (3)
- [F1]This option represents a right to purchase up to 30,870 shares of common stock, which option vests with respect to 100% of the total number of shares on January 10, 2026.
- [F2]Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's common stock upon settlement for no consideration.
- [F3]100% of the total restricted stock units will vest on January 10, 2026.